Device type · FTR
Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
FTR
General & Plastic Surgery
Device class
Class III
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
32,933
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled
- Product code
- FTR
- Device class
- Class III
- Review panel
- General & Plastic Surgery
- Regulation
- 21 CFR 878.3540
- FDA record
- Classification database entry for FTR
Latest FDA decisions
P230005 · Decided Sep 26, 2024 · 580 days after receipt
Device type: Prosthesis, breast, noninflatable, internal, silicone gel-filled (FTR) · General & Plastic Surgery
Reports received
32,933
Received Nov 1, 2025 to Nov 19, 2026. Includes 53 of another or unstated type.
Malfunction reports
474
1.4% of reports
Injury reports
32,402
98% of reports
Death reports
4
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 21 | 1,978 | 1 | 1 |
| Jan 24 | 23 | 2,389 | 0 | 0 |
| Feb 24 | 33 | 2,538 | 1 | 0 |
| Mar 24 | 36 | 2,637 | 1 | 3 |
| Apr 24 | 35 | 2,608 | 0 | 0 |
| May 24 | 37 | 2,474 | 0 | 0 |
| Jun 24 | 39 | 2,312 | 0 | 0 |
| Jul 24 | 29 | 2,528 | 0 | 1 |
| Aug 24 | 47 | 2,448 | 0 | 0 |
| Sep 24 | 29 | 2,423 | 0 | 0 |
| Oct 24 | 43 | 2,631 | 0 | 0 |
| Nov 24 | 37 | 2,422 | 0 | 0 |
| Dec 24 | 45 | 2,440 | 0 | 0 |
| Jan 25 | 22 | 2,363 | 0 | 0 |
| Feb 25 | 37 | 2,429 | 0 | 0 |
| Mar 25 | 34 | 2,454 | 0 | 0 |
| Apr 25 | 36 | 2,574 | 0 | 0 |
| May 25 | 46 | 2,559 | 0 | 0 |
| Jun 25 | 40 | 2,503 | 0 | 0 |
| Jul 25 | 38 | 2,682 | 0 | 0 |
| Aug 25 | 46 | 2,493 | 0 | 0 |
| Sep 25 | 67 | 2,574 | 0 | 0 |
| Oct 25 | 44 | 2,835 | 0 | 0 |
| Nov 25 | 56 | 2,502 | 0 | 1 |
| Dec 25 | 35 | 2,923 | 0 | 0 |
| Jan 26 | 40 | 2,650 | 0 | 4 |
| Feb 26 | 26 | 2,570 | 0 | 1 |
| Mar 26 | 51 | 2,852 | 0 | 0 |
| Apr 26 | 40 | 2,894 | 0 | 1 |
| May 26 | 34 | 2,797 | 0 | 0 |
| Jun 26 | 41 | 2,891 | 1 | 2 |
| Jul 26 | 47 | 2,669 | 2 | 0 |
| Aug 26 | 35 | 2,633 | 0 | 9 |
| Sep 26 | 44 | 2,709 | 0 | 17 |
| Oct 26 | 25 | 2,312 | 1 | 18 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Allergan Costa Rica17,903
- Mentor Texas11,039
- Establishment Labs1,759
- Unknown141
- Unk123
- Allergan28
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Material Rupture14,902
- Device Appears to Trigger Rejection9,793
- Adverse Event Without Identified Device or Use Problem6,395
- Migration1,343
- Patient Device Interaction Problem1,027
- Malposition of Device922
- Gel Leak828
- Break646
- No Apparent Adverse Event332
- Patient-Device Incompatibility186
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Capsular Contracture15,977
- No Clinical Signs, Symptoms or Conditions6,867
- Failure of Implant3,960
- Deformity/ Disfigurement3,193
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available814
- Seroma754
- Breast Discomfort/Pain746
- Rupture673
- Insufficient Information551
- Unspecified Infection344
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0700-2020 · Started Nov 6, 2019
Reason given: The firm has became aware that 2D barcodes on breast implants and sizers may be unreadable by GS-1 configured scanners. These 2D barcodes contain a group separators between fixed-length element string in the UDI data chain of the 2D barcode, which is not formatted to the GS1 standard.
Cause as FDA categorized it: Error in labeling
Z-0701-2020 · Started Nov 6, 2019
Reason given: The firm has became aware that 2D barcodes on breast implants and sizers may be unreadable by GS-1 configured scanners. These 2D barcodes contain a group separators between fixed-length element string in the UDI data chain of the 2D barcode, which is not formatted to the GS1 standard.
Cause as FDA categorized it: Error in labeling
Z-2452-2019 · Started Jul 24, 2019 · Posted by FDA Sep 11, 2019
Reason given: The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
Cause as FDA categorized it: Unknown/Undetermined by firm
- Natrelle Inspira, Silicone-Filled Breast Implants, Sterile, for the following style numbers: Style TRL:...Open, Classified
Z-2453-2019 · Started Jul 24, 2019 · Posted by FDA Sep 11, 2019
Reason given: The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
Cause as FDA categorized it: Unknown/Undetermined by firm
Z-2454-2019 · Started Jul 24, 2019 · Posted by FDA Sep 11, 2019
Reason given: The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
Cause as FDA categorized it: Unknown/Undetermined by firm
- McGhan BioDIMENSIONAL silicone-Filled Breast Implants, style 153 Product Usage: Breast augmentation and Breast reconstructionOpen, Classified
Z-2459-2019 · Started Jul 24, 2019 · Posted by FDA Sep 11, 2019
Reason given: The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
Cause as FDA categorized it: Unknown/Undetermined by firm
Z-2460-2019 · Started Jul 24, 2019 · Posted by FDA Sep 11, 2019
Reason given: The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
Cause as FDA categorized it: Unknown/Undetermined by firm
- Natrelle 510, TruForm, Dual-Gel, BIOCELL, Styles LX, MX, FX Product Usage: Breast augmentation and Breast reconstructionOpen, Classified
Z-2461-2019 · Started Jul 24, 2019 · Posted by FDA Sep 11, 2019
Reason given: The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.
Cause as FDA categorized it: Unknown/Undetermined by firm
Showing the 8 newest of 14 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.